Impaired fasting glucose: Pro-diabetic, "atheroprotective" and modified by metabolic syndrome

Tarih
2013
Yazar
Koroglu, Bayram
Kaya, Aysem
ADEMOĞLU, Evin
ÇAKMAK, Hikmet
Onat, Altan
Aydin, Mesut
CAN, Gunay
Üst veri
Tüm öğe kaydını göster
Özet
AIM: To investigate whether impaired fasting glucose (IFG) confers cardiovascular risk.
Bağlantı
http://hdl.handle.net/20.500.12627/167776
https://doi.org/10.4239/wjd.v4.i5.210
Koleksiyonlar